HEALTH CATALYST INC's ticker is HCAT and the CUSIP is 42225T107. A total of 175 filers reported holding HEALTH CATALYST INC in Q3 2022. The put-call ratio across all filers is 0.40 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,166,736 | -13.0% | 905,804 | +7.5% | 2.81% | -13.5% |
| Q2 2023 | $10,534,238 | +13.7% | 842,739 | +6.2% | 3.25% | +5.4% |
| Q1 2023 | $9,261,067 | -11.3% | 793,579 | -19.2% | 3.08% | -11.9% |
| Q4 2022 | $10,441,647 | +30.2% | 982,281 | +18.8% | 3.50% | +20.6% |
| Q3 2022 | $8,020,000 | -17.4% | 826,841 | +237.2% | 2.90% | +2.9% |
| Q4 2021 | $9,714,000 | -9.7% | 245,186 | +14.0% | 2.82% | -16.9% |
| Q3 2021 | $10,760,000 | -8.2% | 215,154 | +1.9% | 3.39% | -8.7% |
| Q2 2021 | $11,724,000 | +12.6% | 211,206 | -5.1% | 3.72% | +12.7% |
| Q1 2021 | $10,412,000 | +19.2% | 222,631 | +11.0% | 3.30% | +3.8% |
| Q4 2020 | $8,734,000 | +21.0% | 200,646 | +1.8% | 3.18% | -8.3% |
| Q3 2020 | $7,217,000 | +18.3% | 197,178 | -5.7% | 3.46% | +17.4% |
| Q2 2020 | $6,099,000 | +8.8% | 209,101 | -2.5% | 2.95% | -21.3% |
| Q1 2020 | $5,608,000 | +34.2% | 214,441 | +83.7% | 3.75% | +76.9% |
| Q4 2019 | $4,178,000 | +34.7% | 116,713 | +7.4% | 2.12% | +18.5% |
| Q3 2019 | $3,101,000 | – | 108,702 | – | 1.79% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Daventry Group, LP | 852,504 | $8,269,000 | 11.18% |
| Nepsis Inc. | 826,841 | $8,020,000 | 2.90% |
| First Light Asset Management, LLC | 1,149,833 | $11,153,000 | 1.13% |
| Bullseye Asset Management LLC | 55,434 | $538,000 | 0.31% |
| Portolan Capital Management | 303,602 | $2,945,000 | 0.31% |
| CVS HEALTH Corp | 32,273 | $313,000 | 0.30% |
| Rock Springs Capital Management LP | 880,000 | $8,536,000 | 0.22% |
| Granahan Investment Management | 648,299 | $6,289,000 | 0.20% |
| Bares Capital Management | 452,400 | $4,388,000 | 0.17% |
| Rhenman & Partners Asset Management AB | 180,000 | $1,588,000 | 0.17% |